Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
Pathum Sookaromdee, Viroj Wiwanitkit – 22 August 2022
Health disparities in chronic liver disease
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew – 21 August 2022 – The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations. Highlighting health disparities, their sources, and consequences in chronic liver disease is fundamental to improving liver health outcomes.
Fibroblast growth factor receptor 1/Klothoβ agonist BFKB8488A improves lipids and liver health markers in patients with diabetes or NAFLD: A phase 1b randomized trial
Chin Wong, Ajit Dash, Jill Fredrickson, Nicholas Lewin‐Koh, Shan Chen, Kenta Yoshida, Yanqiu Liu, Johnny Gutierrez, Rebecca Kunder – 21 August 2022
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
Sandra Torres, Cristina Ortiz, Nadine Bachtler, Wenyi Gu, Leon D. Grünewald, Nico Kraus, Robert Schierwagen, Christoph Hieber, Caroline Meier, Olaf Tyc, Maximilian Joseph Brol, Frank Erhard Uschner, Bart Nijmeijer, Christoph Welsch, Marie‐Luise Berres, Carmen Garcia‐Ruiz, Jose Carlos Fernandez‐Checa, Christian Trautwein, Thomas J. Vogl, Stefan Zeuzem, Jonel Trebicka, Sabine Klein – 21 August 2022
Genetic predisposition to porto‐sinusoidal vascular disorder: A functional genomic‐based, multigenerational family study
Jingxuan Shan, André Megarbane, Aziz Chouchane, Deepak Karthik, Ramzi Temanni, Atilio Reyes Romero, Huiying Hua, Chun Pan, Xixi Chen, Murugan Subramanian, Chadi Saad, Hamdi Mbarek, Cybel Mehawej, Eliane Chouery, Sirin W. Abuaqel, Alexander Dömling, Sami Remadi, Cesar Yaghi, Pu Li, Lotfi Chouchane – 20 August 2022
Attacking the public health crisis of hepatocellular carcinoma at its roots
Hannah M. Lee, Steven D. Lidofsky, Tamar H. Taddei, Lisa J. Townshend‐Bulson – 20 August 2022 – As the third most common cause of cancer‐related death worldwide with significant mortality rates in the United States, hepatocellular carcinoma has strong association with cirrhosis and chronic hepatitis B virus (HBV) with a growing at‐risk population from the rise in chronic liver disease from alcohol use and nonalcoholic fatty liver disease.
Letter to the editor: Adipose lipolysis is important for ethanol to induce fatty liver in the NIAAA murine model of chronic and binge ethanol feeding
Wenhao Luo, Yawen Wang, Ye Li, Taiping Zhang – 20 August 2022
Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population
Prowpanga Udompap, Terry M. Therneau, Rachel E. Canning, Joanne T. Benson, Alina M. Allen – 20 August 2022
Early experiences with developing techniques for pure laparoscopic explant hepatectomy in living donor liver transplantation
Jane Chungyoon Kim, Suk Kyun Hong, Kwang‐Woong Lee, Sola Lee, Sanggyun Suh, Su young Hong, Eui Soo Han, YoungRok Choi, Nam‐Joon Yi, Kyung‐Suk Suh – 20 August 2022 – In recent years, laparoscopic techniques for liver resection or living donor hepatectomy have become common surgical methods. However, reports on laparoscopic surgeries for recipients are lacking. Our center has launched the minimally invasive living donor liver transplantation (LDLT) program in March 2020, which is led by two surgeons who are experienced in laparoscopic surgeries.
AIF1+CSF1R+MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei – 20 August 2022